HP 129Xe MRI for Evaluation of CLAD in Lung Transplant Recipients

NCT05550662 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Recruitment challenges

Conditions

Lung Transplant Rejection

Interventions

DRUG: 129Xenon

Sponsor

The Hospital for Sick Children

Collaborators

[object Object]